Related Experiment Videos
Hemochromatosis: how much iron is too much?
Hepatology (Baltimore, Md.)
|January 1, 1986
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study.
Journal of viral hepatitis·2016
Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.
Journal of viral hepatitis·2016
Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy.
Alimentary pharmacology & therapeutics·2010
Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol.
Alimentary pharmacology & therapeutics·2008
Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.
American journal of physiology. Gastrointestinal and liver physiology·2006
Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.
Hepatology (Baltimore, Md.)·2026
Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.
Hepatology (Baltimore, Md.)·2026
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
Hepatology (Baltimore, Md.)·2026